Bank of New York Mellon’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.7M Buy
173,375
+86,282
+99% +$6.94M ﹤0.01% 1816
2026
Q1
$6.57M Sell
87,093
-3,088
-3% -$227K ﹤0.01% 2163
2025
Q4
$6.12M Buy
90,181
+5,475
+6% +$342K ﹤0.01% 2207
2025
Q3
$4.83M Buy
84,706
+2,191
+3% +$130K ﹤0.01% 2337
2025
Q2
$4.57M Buy
82,515
+1,918
+2% +$90K ﹤0.01% 2313
2025
Q1
$3.52M Buy
80,597
+53
+0.1% +$2.31K ﹤0.01% 2401
2024
Q4
$3.47M Buy
80,544
+5,583
+7% +$251K ﹤0.01% 2486
2024
Q3
$3.35M Sell
74,961
-9,325
-11% -$386K ﹤0.01% 2500
2024
Q2
$3.24M Buy
+84,286
New +$3.21M ﹤0.01% 2545
2024
Q1
Sell
-16,951
Closed -$491K 4197
2023
Q4
$491K Buy
+16,951
New +$386K ﹤0.01% 3561

Other funds holding DBD

Bank of New York Mellon's DBD Position: Q2 2026 in Review

Bank of New York Mellon increased its Diebold Nixdorf (DBD) stake by 99% in Q2 2026, buying an estimated $6.94M and bringing the position to 173,375 shares worth $14.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1816.

Bank of New York Mellon first reported a position in DBD in Q4 2023 and has held it in 10 quarters since. 85 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Bank of New York Mellon held 173,375 shares of Diebold Nixdorf worth $14.7M as of Q2 2026.
  • Bank of New York Mellon bought 86,282 Diebold Nixdorf shares in Q2 2026, an estimated $6.94M.
  • Diebold Nixdorf made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1816 holding.
  • Bank of New York Mellon first reported a position in Diebold Nixdorf in Q4 2023 and has held it in 10 quarters since.
  • 85 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.